Stocks News

LAST PRICE
287.3600
TODAY'S CHANGE (%)
Trending Up5.5000 (1.9513%)

Bid / Lots
287.1300/ 1
Ask / Lots
287.4600/ 4
Open / Previous Close
280.2900 / 281.8600
Day Range
Low 279.3100
High 288.3500
52 Week Range
Low 208.6249
High 288.3500
Volume
299,818
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- Wells Fargo Raises Price Target on United Therapeutics to $350 From $325, Maintains Overweight Rating, from 9:17AM ET on Wednesday Jun 12, 2024 by MT Newswires
  9:17AM ET on Wednesday Jun 12, 2024 by MT Newswires
  Companies Mentioned: UTHR
  09:17 AM EDT, 06/12/2024 (MT Newswires) -- United Therapeutics (UTHR) has an average outperform rating and a price target range of $220 to $400, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research...
- DJ United Therapeutics Is Maintained at Overweight by Wells Fargo, from 8:37AM ET on Wednesday Jun 12, 2024 by Dow Jones
  8:37AM ET on Wednesday Jun 12, 2024 by Dow Jones
  Companies Mentioned: UTHR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/UTHR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  June 12, 2024 08:37 ET (12:37 GMT)
Jun 5, 2024
- United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 7:00AM ET on Wednesday Jun 05, 2024 by Business Wire
  7:00AM ET on Wednesday Jun 05, 2024 by Business Wire
  Companies Mentioned: UTHR
  United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Patrick Poisson, Executive Vice President, Technical Operations, will provide an overview and update on the company's operations during a fireside chat session at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, Florida.
- United Therapeutics Corporation to Present at the Goldman Sachs 45(th) Annual Global Healthcare Conference, from 7:00AM ET on Wednesday Jun 05, 2024 by Dow Jones
  7:00AM ET on Wednesday Jun 05, 2024 by Dow Jones
  Companies Mentioned: UTHR
  SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--June 05, 2024--
  United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Patrick Poisson, Executive Vice President, Technical Operations, will provide an overview and update on the company's operations during a fireside chat session at the Goldman Sachs 45(th) Annual Global Healthcare Conference in Miami Beach, Florida.
Jun 3, 2024
- Liquidia's Yutrepia Launch Cleared as Court Denies Injunction, from 8:41AM ET on Monday Jun 03, 2024 by MT Newswires
  8:41AM ET on Monday Jun 03, 2024 by MT Newswires
  Companies Mentioned: UTHR, LQDA
  08:41 AM EDT, 06/03/2024 (MT Newswires) -- Liquidia (LQDA) said Monday that the US District Court for the District of Delaware rejected a motion by United Therapeutics (UTHR) to block the launch of its inhalation powder, Yutrepia to treat pulmonary ...

Jun 10, 2024
- KKR & Co, CrowdStrike, GoDaddy to Join S&P 500 Index on June 24, from 6:38AM ET on Monday Jun 10, 2024 by MT Newswires
  6:38AM ET on Monday Jun 10, 2024 by MT Newswires
  Companies Mentioned: IART, ILMN, LEG, MCS, MED, MEI, OSUR, PENN, CLDT, RBA, RGP, RHI, KKR, TDW, TPL, TTEC, WERN, ADTN, KRYS, ALTR, WHD, ATNI, HOUS, CRWD, GO, CRNC, WMG, STEP, BMRN, HTZ, XPER, CMA, NXT, GDDY, VIRT, NFBK
Jun 7, 2024
- Medpace Holdings Insider Sold Shares Worth $3,081,617, According to a Recent SEC Filing, from 4:21PM ET on Friday Jun 07, 2024 by MT Newswires
  4:21PM ET on Friday Jun 07, 2024 by MT Newswires
  Companies Mentioned: MEDP
- BioMarin Pharmaceutical Reports New Data Affirming Long-Term Safety, Efficacy of Roctavian, from 10:25AM ET on Friday Jun 07, 2024 by MT Newswires
  10:25AM ET on Friday Jun 07, 2024 by MT Newswires
  Companies Mentioned: BMRN
Jun 6, 2024
- Qiagen Scraps NeuMoDx 96, 288 Molecular Systems; Raises 2024 Adjusted Earnings Outlook, from 5:34PM ET on Thursday Jun 06, 2024 by MT Newswires
  5:34PM ET on Thursday Jun 06, 2024 by MT Newswires
  Companies Mentioned: QGEN
May 31, 2024
- Qiagen, Myriad Genetics Partner to Create Easily Distributable Cancer Tumor Test, from 4:14AM ET on Friday May 31, 2024 by MT Newswires
  4:14AM ET on Friday May 31, 2024 by MT Newswires
  Companies Mentioned: MYGN, QGEN
- Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing, from 3:49AM ET on Friday May 31, 2024 by MT Newswires
  3:49AM ET on Friday May 31, 2024 by MT Newswires
  Companies Mentioned: NBIX
- BioMarin Pharmaceutical Insider Sold Shares Worth $3,043,802, According to a Recent SEC Filing, from 3:38AM ET on Friday May 31, 2024 by MT Newswires
  3:38AM ET on Friday May 31, 2024 by MT Newswires
  Companies Mentioned: BMRN
May 29, 2024
- Medpace Holdings Insider Sold Shares Worth $3,828,058, According to a Recent SEC Filing, from 4:28PM ET on Wednesday May 29, 2024 by MT Newswires
  4:28PM ET on Wednesday May 29, 2024 by MT Newswires
  Companies Mentioned: MEDP
- TD Cowen Starts Medpace Holdings With Buy Rating, $452 Price Target, from 7:45AM ET on Wednesday May 29, 2024 by MT Newswires
  7:45AM ET on Wednesday May 29, 2024 by MT Newswires
  Companies Mentioned: MEDP
May 28, 2024
- Neurocrine Biosciences Says CEO Kevin Gorman Retiring, from 5:09PM ET on Tuesday May 28, 2024 by MT Newswires
  5:09PM ET on Tuesday May 28, 2024 by MT Newswires
  Companies Mentioned: NBIX

United Therapeutics Corp
NASDAQ:UTHRUnited States

Search Criteria

Yesterday

Wells Fargo Raises Price Target on United Therapeutics to $350 From $325, Maintains Overweight Rating, from 9:17AM ET on Wednesday Jun 12, 2024 by MT Newswires

DJ United Therapeutics Is Maintained at Overweight by Wells Fargo, from 8:37AM ET on Wednesday Jun 12, 2024 by Dow Jones

Jun 5, 2024

United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 7:00AM ET on Wednesday Jun 05, 2024 by Business Wire

United Therapeutics Corporation to Present at the Goldman Sachs 45(th) Annual Global Healthcare Conference, from 7:00AM ET on Wednesday Jun 05, 2024 by Dow Jones

Jun 3, 2024

Liquidia's Yutrepia Launch Cleared as Court Denies Injunction, from 8:41AM ET on Monday Jun 03, 2024 by MT Newswires

Peers Headlines

Jun 10, 2024

KKR & Co, CrowdStrike, GoDaddy to Join S&P 500 Index on June 24, from 6:38AM ET on Monday Jun 10, 2024 by MT Newswires

Jun 7, 2024

Medpace Holdings Insider Sold Shares Worth $3,081,617, According to a Recent SEC Filing, from 4:21PM ET on Friday Jun 07, 2024 by MT Newswires

BioMarin Pharmaceutical Reports New Data Affirming Long-Term Safety, Efficacy of Roctavian, from 10:25AM ET on Friday Jun 07, 2024 by MT Newswires

Jun 6, 2024

Qiagen Scraps NeuMoDx 96, 288 Molecular Systems; Raises 2024 Adjusted Earnings Outlook, from 5:34PM ET on Thursday Jun 06, 2024 by MT Newswires

May 31, 2024

Qiagen, Myriad Genetics Partner to Create Easily Distributable Cancer Tumor Test, from 4:14AM ET on Friday May 31, 2024 by MT Newswires

Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing, from 3:49AM ET on Friday May 31, 2024 by MT Newswires

BioMarin Pharmaceutical Insider Sold Shares Worth $3,043,802, According to a Recent SEC Filing, from 3:38AM ET on Friday May 31, 2024 by MT Newswires

May 29, 2024

Medpace Holdings Insider Sold Shares Worth $3,828,058, According to a Recent SEC Filing, from 4:28PM ET on Wednesday May 29, 2024 by MT Newswires

TD Cowen Starts Medpace Holdings With Buy Rating, $452 Price Target, from 7:45AM ET on Wednesday May 29, 2024 by MT Newswires

May 28, 2024

Neurocrine Biosciences Says CEO Kevin Gorman Retiring, from 5:09PM ET on Tuesday May 28, 2024 by MT Newswires